Intercept Pharmaceuticals ICPT Stock
Intercept Pharmaceuticals Price Chart
Intercept Pharmaceuticals ICPT Financial and Trading Overview
| Intercept Pharmaceuticals stock price | 19 USD |
| Previous Close | 12.04 USD |
| Open | 11.96 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 11.65 - 12.06 USD |
| 52 Week Range | 8.82 - 21.86 USD |
| Volume | 1.43M USD |
| Avg. Volume | 1.19M USD |
| Market Cap | 492.74M USD |
| Beta (5Y Monthly) | 1.266549 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.92 USD |
ICPT Valuation Measures
| Enterprise Value | 401.36M USD |
| Trailing P/E | N/A |
| Forward P/E | 13.133333 |
| PEG Ratio (5 yr expected) | 0.65 |
| Price/Sales (ttm) | 1.6730211 |
| Price/Book (mrq) | 7.332506 |
| Enterprise Value/Revenue | 1.363 |
| Enterprise Value/EBITDA | -5.492 |
Trading Information
Intercept Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.266549 |
| 52-Week Change | -0.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.86 USD |
| 52 Week Low | 8.82 USD |
| 50-Day Moving Average | 14.46 USD |
| 200-Day Moving Average | 15.49 USD |
ICPT Share Statistics
| Avg. Volume (3 month) | 1.19M USD |
| Avg. Daily Volume (10-Days) | 1.15M USD |
| Shares Outstanding | 41.69M |
| Float | 36.56M |
| Short Ratio | 2.99 |
| % Held by Insiders | 3.20% |
| % Held by Institutions | 79.58% |
| Shares Short | 5.17M |
| Short % of Float | 12.88% |
| Short % of Shares Outstanding | 12.40% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 70.27% |
| Operating Margin (ttm) | -24.92% |
| Gross Margin | 99.66% |
| EBITDA Margin | -24.81% |
Management Effectiveness
| Return on Assets (ttm) | -9.10% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 294.52M USD |
| Revenue Per Share (ttm) | 8 USD |
| Quarterly Revenue Growth (yoy) | 14.89% |
| Gross Profit (ttm) | 284.73M USD |
| EBITDA | -73080000 USD |
| Net Income Avi to Common (ttm) | -173304000 USD |
| Diluted EPS (ttm) | -4.88 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 433.6M USD |
| Total Cash Per Share (mrq) | 10.4 USD |
| Total Debt (mrq) | 333.04M USD |
| Total Debt/Equity (mrq) | 495.71 USD |
| Current Ratio (mrq) | 2.368 |
| Book Value Per Share (mrq) | 1.612 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -58253000 USD |
| Levered Free Cash Flow (ttm) | -59678124 USD |
Profile of Intercept Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Morristown |
| Address | 305 Madison Avenue |
| ZIP | 07960 |
| Phone | 646 747 1000 |
| Website | https://www.interceptpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 341 |
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis and NASH; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in Morristown, New Jersey.
Q&A For Intercept Pharmaceuticals Stock
What is a current ICPT stock price?
Intercept Pharmaceuticals ICPT stock price today per share is 19 USD.
How to purchase Intercept Pharmaceuticals stock?
You can buy ICPT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Intercept Pharmaceuticals?
The stock symbol or ticker of Intercept Pharmaceuticals is ICPT.
Which industry does the Intercept Pharmaceuticals company belong to?
The Intercept Pharmaceuticals industry is Biotechnology.
How many shares does Intercept Pharmaceuticals have in circulation?
The max supply of Intercept Pharmaceuticals shares is 41.83M.
What is Intercept Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Intercept Pharmaceuticals PE Ratio is 0.00000000 now.
What was Intercept Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Intercept Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Intercept Pharmaceuticals company belong to?
The Intercept Pharmaceuticals sector is Healthcare.
Intercept Pharmaceuticals ICPT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| Dow Jones U.S. Biotechnology In DJUSBT | 2546.24 USD — |
+1.18
|
112.43M USD — | 2520.89 USD — | 2551.19 USD — | — - | 112.43M USD — |
| NASDAQ Biotechnology NBI | 4184.77 USD — |
+1.29
|
— — | 4144.83 USD — | 4202.15 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 21258.23 USD — |
-0.1
|
— — | 20967.6 USD — | 21382.13 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4157.43 USD — |
+0.21
|
— — | 3927.42 USD — | 4157.43 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4527.84 USD — |
+1.29
|
— — | 4484.64 USD — | 4546.65 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8495.19 USD — |
-0.11
|
— — | 8378.66 USD — | 8543.96 USD — | — - | — — |
- {{ link.label }} {{link}}